Equity Overview
Price & Market Data
Price: $31.35
Daily Change: -$0.235 / 0.75%
Range: $31.12 - $31.95
Market Cap: $0
Volume: 8,373
Performance Metrics
1 Week: 4.24%
1 Month: 11.96%
3 Months: 4.01%
6 Months: -18.67%
1 Year: -9.35%
YTD: -5.09%
Details
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.